Safety Monitoring of Disease-Modifying Therapies in Multiple

Name: Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
Uploaded: 2024-05-02T17:03:32
Description: Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Learning, Laughing, and Living with Multiple Sclerosis
Learning, Laughing, and Living with Multiple Sclerosis
MS & Immune Disorders
Learning, Laughing, and Living with Multiple Sclerosis
Ardra Shephard; Jiwon Oh, MD, PhD
Ardra Shephard; Jiwon Oh, MD, PhD
Approaches to MS Care in Later Life: Distinguishing Aging from Disease
Approaches to MS Care in Later Life: Distinguishing Aging from Disease
MS & Immune Disorders
Approaches to MS Care in Later Life: Distinguishing Aging from Disease
Yinan Zhang, MD
Yinan Zhang, MD
Neuro-Ophthalmology Notions: Retinal Artery Occlusion—Diagnosis and Treatment Considerations
Neuro-Ophthalmology Notions: Retinal Artery Occlusion—Diagnosis and Treatment Considerations
MS & Immune Disorders
Neuro-Ophthalmology Notions: Retinal Artery Occlusion—Diagnosis and Treatment Considerations
Rachel Aubert, DO; Sergio Garces, MD
Rachel Aubert, DO; Sergio Garces, MD
Fluid Biomarkers in Multiple Sclerosis
Fluid Biomarkers in Multiple Sclerosis
MS & Immune Disorders
Fluid Biomarkers in Multiple Sclerosis
Kinjal Thakor, MD; Marwa Kaisey, MD
Kinjal Thakor, MD; Marwa Kaisey, MD